ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Isis Pharmaceuticals


Include trials that are no longer recruiting patients.

12 studies were found.
1.No longer recruitingAddition of ISIS 14803 to Therapy with Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) patients not Responding Adequately to the Two Drugs
Condition: Hepatitis C, Chronic
2.No longer recruitingAlicaforsen (ISIS 2302) in Patients with Active Crohn’s Disease
Condition: Crohn's Disease
3.No longer recruitingAlicaforsen (ISIS 2302) in Patients with Active Crohn’s Disease
Condition: Crohn's Disease
4.CompletedCarboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
5.CompletedA Comparison of ISIS 2922 Used Immediately or Later in Patients with Cytomegalovirus (CMV) of the Eyes
Conditions: Cytomegalovirus Retinitis; HIV Infections
6.No longer recruitingISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
7.No longer recruitingISIS 14803-CS2, Treatment with ISIS 14803, Administered IV in Patients with Chronic Hepatitis C Virus Infections
Condition: Hepatitis C, Chronic
8.No longer recruitingISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients with Mild to Moderate Active Ulcerative Colitis
Condition: Ulcerative Colitis
9.No longer recruitingISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients with Mild to Moderate Active Ulcerative Colitis.
Condition: Ulcerative Colitis
10.CompletedA Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
Conditions: Cytomegalovirus Retinitis; HIV Infections
11.CompletedThe Safety and Effectiveness of ISIS 2922 in Patients with AIDS Who Have Cytomegalovirus (CMV) of the Eyes
Conditions: Cytomegalovirus Retinitis; HIV Infections
12.CompletedA Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
Conditions: Cytomegalovirus Retinitis; HIV Infections

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act